|
121 |
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: the NOA-18 trial
Enthalten in BMC cancer Bd. 22, 13.6.2022, Nr. 1, date:12.2022: 1-12
|
|
|
|
122 |
Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation
Enthalten in Journal of neuro-oncology Bd. 159, 17.7.2022, Nr. 3, date:9.2022: 509-518
|
|
|
|
123 |
Infratentorial IDH-mutant astrocytoma is a distinct subtype
Enthalten in Acta neuropathologica Bd. 140, 10.8.2020, Nr. 4, date:10.2020: 569-581
|
|
|
|
124 |
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas
Enthalten in Acta neuropathologica Bd. 146, 26.7.2023, Nr. 3, date:9.2023: 499-514
|
|
|
|
125 |
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas
Enthalten in Neurological research and practice Bd. 5, 19.10.2023, Nr. 1, date:12.2023: 1-6
|
|
|
|
126 |
Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen
Enthalten in Journal of neurology Bd. 272, 14.3.2025, Nr. 4, date:4.2025: 1-17
|
|
|
|
127 |
Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients
Enthalten in Journal of neuro-oncology Bd. 145, 2.11.2019, Nr. 3, date:12.2019: 531-540
|
|
|
|
128 |
Loss of histone H3K27me3 identifies a subset of meningiomas with increased risk of recurrence
Enthalten in Acta neuropathologica Bd. 135, 7.4.2018, Nr. 6, date:6.2018: 955-963
|
|
|
|
129 |
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma
Enthalten in Acta neuropathologica Bd. 148, 8.8.2024, Nr. 1, date:12.2024: 1-4
|
|
|
|
130 |
Meningeosis neoplastica
Enthalten in Info Neurologie & Psychiatrie Bd. 18, 26.9.2016, Nr. 9, date:9.2016: 40-50
|
|
Administration
